ROYCE & ASSOCIATES LP - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 141 filers reported holding NOVAVAX INC in Q4 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of NOVAVAX INC
ValueSharesWeighting
Q1 2018$819,000
+20.1%
390,000
-29.1%
0.01%
+20.0%
Q4 2017$682,000
+8.8%
550,0000.0%0.01%
+25.0%
Q3 2017$627,000
-0.9%
550,0000.0%0.00%0.0%
Q2 2017$633,000
-10.1%
550,0000.0%0.00%
-20.0%
Q1 2017$704,000
+1.6%
550,0000.0%0.01%
+25.0%
Q4 2016$693,000
-63.0%
550,000
-38.9%
0.00%
-66.7%
Q3 2016$1,872,000900,0000.01%
Other shareholders
NOVAVAX INC shareholders Q4 2017
NameSharesValueWeighting ↓
Caption Management, LLC 2,021,600$22,273,0001.23%
GREAT POINT PARTNERS LLC 4,500,000$2,479,0000.24%
SABBY MANAGEMENT, LLC 860,000$474,0000.23%
Sargent Investment Group, LLC 588,070$324,0000.16%
BB BIOTECH AG 8,330,000$4,589,0000.12%
GREAT POINT PARTNERS LLC 2,000,000$1,102,0000.11%
CENTAURUS FINANCIAL, INC. 7$12,000,0000.07%
Rock Springs Capital Management LP 3,250,000$1,790,0000.07%
Beirne Wealth Consulting Services, LLC 155,000$85,0000.07%
ACUTA CAPITAL PARTNERS, LLC 250,000$138,0000.07%
View complete list of NOVAVAX INC shareholders